377 related articles for article (PubMed ID: 31848580)
1. Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease.
Crapser JD; Ochaba J; Soni N; Reidling JC; Thompson LM; Green KN
Brain; 2020 Jan; 143(1):266-288. PubMed ID: 31848580
[TBL] [Abstract][Full Text] [Related]
2. Microglial physiological properties and interactions with synapses are altered at presymptomatic stages in a mouse model of Huntington's disease pathology.
Savage JC; St-Pierre MK; Carrier M; El Hajj H; Novak SW; Sanchez MG; Cicchetti F; Tremblay MÈ
J Neuroinflammation; 2020 Apr; 17(1):98. PubMed ID: 32241286
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
Elife; 2021 Apr; 10():. PubMed ID: 33871358
[TBL] [Abstract][Full Text] [Related]
4. Partial reduction of microglia does not affect tau pathology in aged mice.
Bennett RE; Bryant A; Hu M; Robbins AB; Hopp SC; Hyman BT
J Neuroinflammation; 2018 Nov; 15(1):311. PubMed ID: 30413160
[TBL] [Abstract][Full Text] [Related]
5. Decreased Myocyte Enhancer Factor 2 Levels in the Hippocampus of Huntington's Disease Mice Are Related to Cognitive Dysfunction.
Vidal-Sancho L; Fernández-García S; Solés-Tarrés I; Alberch J; Xifró X
Mol Neurobiol; 2020 Nov; 57(11):4549-4562. PubMed ID: 32757160
[TBL] [Abstract][Full Text] [Related]
6. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease.
Luis-Ravelo D; Estévez-Silva H; Barroso-Chinea P; Afonso-Oramas D; Salas-Hernández J; Rodríguez-Núñez J; Acevedo-Arozena A; Marcellino D; González-Hernández T
Exp Neurol; 2018 Jan; 299(Pt A):137-147. PubMed ID: 29056363
[TBL] [Abstract][Full Text] [Related]
7. Alpha-synuclein inclusion responsive microglia are resistant to CSF1R inhibition.
Stoll AC; Kemp CJ; Patterson JR; Kubik M; Kuhn N; Benskey M; Duffy MF; Luk KC; Sortwell CE
J Neuroinflammation; 2024 Apr; 21(1):108. PubMed ID: 38664840
[TBL] [Abstract][Full Text] [Related]
8. Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6/2 mouse model of Huntington's disease.
Samadi P; Boutet A; Rymar VV; Rawal K; Maheux J; Kvann JC; Tomaszewski M; Beaubien F; Cloutier JF; Levesque D; Sadikot AF
Genes Brain Behav; 2013 Feb; 12(1):108-24. PubMed ID: 23006318
[TBL] [Abstract][Full Text] [Related]
9. Human Huntington's disease pluripotent stem cell-derived microglia develop normally but are abnormally hyper-reactive and release elevated levels of reactive oxygen species.
O'Regan GC; Farag SH; Casey CS; Wood-Kaczmar A; Pocock JM; Tabrizi SJ; Andre R
J Neuroinflammation; 2021 Apr; 18(1):94. PubMed ID: 33874957
[TBL] [Abstract][Full Text] [Related]
10. Microglia facilitate loss of perineuronal nets in the Alzheimer's disease brain.
Crapser JD; Spangenberg EE; Barahona RA; Arreola MA; Hohsfield LA; Green KN
EBioMedicine; 2020 Aug; 58():102919. PubMed ID: 32745992
[TBL] [Abstract][Full Text] [Related]
11. Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.
Palazuelos J; Aguado T; Pazos MR; Julien B; Carrasco C; Resel E; Sagredo O; Benito C; Romero J; Azcoitia I; Fernández-Ruiz J; Guzmán M; Galve-Roperh I
Brain; 2009 Nov; 132(Pt 11):3152-64. PubMed ID: 19805493
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of GSK-3 ameliorates the pathogenesis of Huntington's disease.
Rippin I; Bonder K; Joseph S; Sarsor A; Vaks L; Eldar-Finkelman H
Neurobiol Dis; 2021 Jul; 154():105336. PubMed ID: 33753290
[TBL] [Abstract][Full Text] [Related]
13. Alleviation of Huntington pathology in mice by oral administration of food additive glyceryl tribenzoate.
Dutta D; Majumder M; Paidi RK; Pahan K
Neurobiol Dis; 2021 Jun; 153():105318. PubMed ID: 33636386
[TBL] [Abstract][Full Text] [Related]
14. Concentration-dependent effects of CSF1R inhibitors on oligodendrocyte progenitor cells ex vivo and in vivo.
Liu Y; Given KS; Dickson EL; Owens GP; Macklin WB; Bennett JL
Exp Neurol; 2019 Aug; 318():32-41. PubMed ID: 31029597
[TBL] [Abstract][Full Text] [Related]
15. Effect of the CSF1R inhibitor PLX3397 on remyelination of corpus callosum in a cuprizone-induced demyelination mouse model.
Tahmasebi F; Pasbakhsh P; Mortezaee K; Madadi S; Barati S; Kashani IR
J Cell Biochem; 2019 Jun; 120(6):10576-10586. PubMed ID: 30628737
[TBL] [Abstract][Full Text] [Related]
16. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease.
Sosna J; Philipp S; Albay R; Reyes-Ruiz JM; Baglietto-Vargas D; LaFerla FM; Glabe CG
Mol Neurodegener; 2018 Mar; 13(1):11. PubMed ID: 29490706
[TBL] [Abstract][Full Text] [Related]
17. Increased calbindin-D28k immunoreactivity in striatal projection neurons of R6/2 Huntington's disease transgenic mice.
Sun Z; Wang HB; Deng YP; Lei WL; Xie JP; Meade CA; Del Mar N; Goldowitz D; Reiner A
Neurobiol Dis; 2005 Dec; 20(3):907-17. PubMed ID: 15990326
[TBL] [Abstract][Full Text] [Related]
18. Early retinal function deficit without prominent morphological changes in the R6/2 mouse model of Huntington's disease.
Ragauskas S; Leinonen H; Puranen J; Rönkkö S; Nymark S; Gurevicius K; Lipponen A; Kontkanen O; Puoliväli J; Tanila H; Kalesnykas G
PLoS One; 2014; 9(12):e113317. PubMed ID: 25469887
[TBL] [Abstract][Full Text] [Related]
19. Cell-intrinsic glial pathology is conserved across human and murine models of Huntington's disease.
Benraiss A; Mariani JN; Osipovitch M; Cornwell A; Windrem MS; Villanueva CB; Chandler-Militello D; Goldman SA
Cell Rep; 2021 Jul; 36(1):109308. PubMed ID: 34233199
[TBL] [Abstract][Full Text] [Related]
20. Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons.
Kraft AD; Kaltenbach LS; Lo DC; Harry GJ
Neurobiol Aging; 2012 Mar; 33(3):621.e17-33. PubMed ID: 21482444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
